Aptevo Therapeutics Inc.

NASDAQ: APVO · Real-Time Price · USD
1.98
-0.06 (-2.94%)
At close: Aug 15, 2025, 3:59 PM
2.02
2.28%
After-hours: Aug 15, 2025, 07:41 PM EDT

Aptevo Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-24.02M -23.7M -24.13M -24.01M -25.25M -27.31M -17.7M -16.15M -17.46M 18.5M 8.03M 6.4M 7.04M -28.9M -28.46M -29.24M -29.03M -27.9M
Depreciation & Amortization
265K 307K 352K 397K 436K 495K 567K 612K 711K 837K 901K 1M 1.07M 1.1M 1.14M 1.23M 1.23M 1.24M
Stock-Based Compensation
94K 530K 1.07M 1.5M 1.8M 2M 2.19M 2.19M 2.1M 2.12M 1.8M 1.62M 1.58M 1.67M 1.64M 1.66M 1.69M 1.42M
Other Working Capital
-167K 352K 230K -213K -93K 1.08M 1.7M -912K -1.17M -515K -576K 2.17M 1.49M -589K 32.07M 64.88M 89.46M 91.02M
Other Non-Cash Items
-2.44M -1.11M 1.56M 2.06M 4.46M 2.78M 933K 463K -343K -35.57M -33.9M -31.66M -29.6M 8.03M 6.64M 4.19M 2.63M 580K
Deferred Income Tax
n/a n/a n/a -201K -979K -630K -630K -429K 349K n/a n/a n/a -1K -1K 4K 4K 5K 5K
Change in Working Capital
1.46M 1.6M 554K 176K -1.58M 1.58M 2.91M 896K 1.58M 2.78M 2.14M 3.68M 2.6M -1.19M -2.65M -1.77M -2.58M -976K
Operating Cash Flow
-24.65M -23.71M -23.79M -23.28M -24.3M -22.95M -11.73M -12.42M -13.07M -11.34M -21.02M -18.96M -17.31M -19.29M -21.68M -23.92M -26.07M -25.65M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a -25K -29K -54K -54K -147K -156K -522K -713K -683K -670K -279K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -28.12M -28.12M -28.12M
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 28.12M 56.24M 56.24M
Investing Cash Flow
n/a n/a n/a n/a n/a n/a n/a -25K -29K -54K -54K -147K -156K -522K -713K -683K 27.45M 27.84M
Debt Repayment
n/a n/a n/a n/a n/a n/a -3.47M -3.97M -4.47M -4.97M -12.27M -11.77M -11.27M -10.77M -10.55M -10.55M -10.55M -10.55M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4K 10.23M 10.23M 10.23M 10.23M -11K -11K -11K
Dividend Paid
n/a n/a n/a -8K -8K -8K -8K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
5.56M 5.56M 5.56M -6K 3.14M 3.14M 3.13M 9.63M 6.49M 3.38M 9.21M -359K -3.47M 7.96M 36.62M 60.95M 88.79M 80.47M
Financial Cash Flow
25.99M 15.6M 15.6M 11.92M 11.36M 7.87M 6M 8.95M 4.11M 447K -2.62M -11.69M -14.21M -2.72M 26.16M 50.48M 78.24M 69.92M
Net Cash Flow
1.34M -8.11M -8.19M -11.36M -12.94M -15.08M -5.73M -3.47M -8.97M -10.92M -23.67M -30.8M -31.68M -22.53M 3.77M 25.88M 51.5M 43.99M
Free Cash Flow
-24.65M -23.71M -23.79M -23.28M -24.3M -22.95M -11.73M -12.44M -13.1M -11.39M -21.08M -19.11M -17.46M -19.81M -22.39M -24.61M -26.74M -25.93M